These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23744877)

  • 1. Benign breast disease, mammographic breast density, and the risk of breast cancer.
    Tice JA; O'Meara ES; Weaver DL; Vachon C; Ballard-Barbash R; Kerlikowske K
    J Natl Cancer Inst; 2013 Jul; 105(14):1043-9. PubMed ID: 23744877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mammographic density and benign breast disease on breast cancer risk (United States).
    Byrne C; Schairer C; Brinton LA; Wolfe J; Parekh N; Salane M; Carter C; Hoover R
    Cancer Causes Control; 2001 Feb; 12(2):103-10. PubMed ID: 11246838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
    Castells X; Domingo L; Corominas JM; Torá-Rocamora I; Quintana MJ; Baré M; Vidal C; Natal C; Sánchez M; Saladié F; Ferrer J; Vernet M; Servitja S; Rodríguez-Arana A; Roman M; Espinàs JA; Sala M
    Breast Cancer Res Treat; 2015 Jan; 149(1):237-44. PubMed ID: 25503778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign breast biopsy diagnosis and subsequent risk of breast cancer.
    Ashbeck EL; Rosenberg RD; Stauber PM; Key CR
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):467-72. PubMed ID: 17337650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.
    Gierach GL; Ichikawa L; Kerlikowske K; Brinton LA; Farhat GN; Vacek PM; Weaver DL; Schairer C; Taplin SH; Sherman ME
    J Natl Cancer Inst; 2012 Aug; 104(16):1218-27. PubMed ID: 22911616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.
    Vierkant RA; Degnim AC; Radisky DC; Visscher DW; Heinzen EP; Frank RD; Winham SJ; Frost MH; Scott CG; Jensen MR; Ghosh K; Manduca A; Brandt KR; Whaley DH; Hartmann LC; Vachon CM
    BMC Cancer; 2017 Jan; 17(1):84. PubMed ID: 28143431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small focal lesions of the breast: a clinico-morphological analysis].
    Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
    Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
    Posso M; Alcántara R; Vázquez I; Comerma L; Baré M; Louro J; Quintana MJ; Román M; Marcos-Gragera R; Vernet-Tomas M; Saladie F; Vidal C; Bargalló X; Peñalva L; Sala M; Castells X;
    Eur Radiol; 2022 Jan; 32(1):621-629. PubMed ID: 34156554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.
    Rubin E; Visscher DW; Alexander RW; Urist MM; Maddox WA
    Cancer; 1988 May; 61(10):2077-82. PubMed ID: 3359405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.
    Abubakar M; Fan S; Bowles EA; Widemann L; Duggan MA; Pfeiffer RM; Falk RT; Lawrence S; Richert-Boe K; Glass AG; Kimes TM; Figueroa JD; Rohan TE; Gierach GL
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33981950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.
    Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
    Breast; 2020 Dec; 54():343-348. PubMed ID: 33023825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
    Visscher DW; Frank RD; Carter JM; Vierkant RA; Winham SJ; Heinzen EP; Broderick BT; Denison LA; Allers TM; Johnson JL; Frost MH; Hartmann LC; Degnim AC; Radisky DC
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28376198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for benign proliferative breast disease.
    Friedenreich C; Bryant H; Alexander F; Hugh J; Danyluk J; Page D
    Int J Epidemiol; 2000 Aug; 29(4):637-44. PubMed ID: 10922339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study.
    Boyd NF; Jensen HM; Cooke G; Han HL; Lockwood GA; Miller AB
    Eur J Cancer Prev; 2000 Feb; 9(1):15-24. PubMed ID: 10777006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The "gray zone" in organized mammography screening: histocytological correlations].
    Bak M; Konyár E; Schneider F; Bidlek M; Szabó E; Nyári T; Godény M; Kásler M
    Orv Hetil; 2011 Feb; 152(8):292-5. PubMed ID: 21310698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast disease and the risk of breast cancer.
    Hartmann LC; Sellers TA; Frost MH; Lingle WL; Degnim AC; Ghosh K; Vierkant RA; Maloney SD; Pankratz VS; Hillman DW; Suman VJ; Johnson J; Blake C; Tlsty T; Vachon CM; Melton LJ; Visscher DW
    N Engl J Med; 2005 Jul; 353(3):229-37. PubMed ID: 16034008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.